Skip to main content
Log in

Determination of Gemcitabine Triphosphate in Peripheral Blood Mononuclear Cells by Reverse-Phase HPLC

  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

This paper describes a high-performance liquid chromatographic assay coupled with UV detection at 272 nm, to determine the levels of the nucleotide analogue gemcitabine triphosphate, one of the active metabolites of the antitumoral drug gemcitabine, in peripheral blood mononuclear cells. Isocratic ion-pair chromatography on a C18 column was used. Samples were treated with trichloroacetic acid 40%, cleaned and neutralized with freon:trioctylamine (4:1). The method was linear on the concentration range tested, and the evaluated precision was found satisfactory (RSD < 6.8). The detection limit was 31 pmol, and the quantitation limit 102 pmol. The recovery of gemcitabine triphosphate ranged between 95 and 114%. The procedure was used to provide pharmacokinetic data from cancer patients treated with intravenous gemcitabine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • van Moorsel CJA, Peters GJ, Pinedo HM (1997) The Oncologist 2:127–134

    PubMed  Google Scholar 

  • Thomas A, Steward WP (1998) Ann Oncol 9:1265–1267

    Google Scholar 

  • Heinemann V, Hertel LW, Grindey GB, Plunkett W (1988) Cancer Res 48:4024–4031

    CAS  PubMed  Google Scholar 

  • van Moorsel CJ, Pinedo HM, Smid K, Comijn EM, Voorn DA, Veerman G, Lakerveld B, van der Vijgh WJ, Giaccone G, Postmus PE, Peters GJ (2000) Eur J Cancer 36:2420–2429

    Article  PubMed  Google Scholar 

  • Sparidans RW, Crul M, Schellens JHM, Beijnen JH (2002) J Chromatogr B 780:423–430

    Article  CAS  Google Scholar 

  • Kroep JR, Giaccone G, Voorn DA, Smit EF, Beijnen JH, Rosing H, van Moorsel CJA, van Groeningen CJ, Postmus PE, Pinedo HM, Peters GJ (1999) J Clin Oncol 17:2190–2197

    CAS  PubMed  Google Scholar 

  • Grunewald R, Kantarjian H, Du M, Faucher K, Tarassoff P, Plunkett W (1992) J Clin Oncol 10:406–413

    CAS  PubMed  Google Scholar 

  • Freeman KB, Anliker S, Hamilton M, Osborne D, Dhahir PH, Nelson R, Allerheiligen SRB (1995) J Chromatogr B 665:171–181

    CAS  PubMed  Google Scholar 

  • Ruiz van Haperen WVT, Veernan G, Boven E, Noordhuis P, Vermorken JB, Peters GJ (1994) Biochem Pharmacol 48:1327–1329

    PubMed  Google Scholar 

  • Decosterd LA, Cottin E, Chen X, Lejeune F, Mirimanoff RO, Biollaz J, Coucke PA (1999) Anal Biochem 270:59–68

    Article  CAS  PubMed  Google Scholar 

  • Winefordner JD, Long GL (1983) Anal Chem 55:712A-724A

    CAS  Google Scholar 

  • Rosing H, Man WY, Doyle E (2000) J Liq Chromatogr Relat Technol 23:329–332

    Article  CAS  Google Scholar 

  • Shah VP, Midha K, Dighe S (1991) Eur J Drug Metab Pharmacokin 16:249–255

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Losa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Losa, R., Sierra, M., Blay, P. et al. Determination of Gemcitabine Triphosphate in Peripheral Blood Mononuclear Cells by Reverse-Phase HPLC. Chromatographia 59, 493–496 (2004). https://doi.org/10.1365/s10337-004-0210-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1365/s10337-004-0210-3

Keywords

Navigation